|Bid||177.41 x 900|
|Ask||177.55 x 1000|
|Day's Range||175.54 - 178.21|
|52 Week Range||108.85 - 209.00|
|Beta (5Y Monthly)||0.51|
|PE Ratio (TTM)||41.50|
|Earnings Date||Oct. 22, 2020 - Oct. 26, 2020|
|Forward Dividend & Yield||1.56 (0.89%)|
|Ex-Dividend Date||May 13, 2020|
|1y Target Est||184.00|
ResMed's (RMD) top line reflects strong segmental and geographic performance boosted by pandemic-led demand growth for ventilators.
ResMed (RMD) delivered earnings and revenue surprises of 37.11% and 8.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended June 30, 2020.